Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2019.239566
PubMed Identifier: 32527951
Publication URI: http://europepmc.org/abstract/MED/32527951
Type: Journal Article/Review
Volume: 106
Parent Publication: Haematologica
Issue: 7
ISSN: 0390-6078